ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Radicava, Suspension zum Einnehmen - 50 ml
68016001 Mitsubishi Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Lenzburg
Radicava, Suspension zum Einnehmen01.05.2023
  01.05.2023
Edaravone (N07XX14) 
WHO-DDD30.04.2028
50 ml
01.99. 
B  
No 
IPCI
PR  
k.A.PR
  
7680680160015Synthetika
  
Composition
edaravonum 105 mg, poly(alcohol vinylicus), xanthani gummi, E 222 5 mg, cysteini hydrochloridum monohydricum, natrii hydroxidum q.s. ad pH, acidum phosphoricum q.s. ad pH, sorbitolum 2000 mg, simeticoni emulsio, aqua purificata, q.s. ad suspensionem pro 5 ml, natrium 1.10 mg.
Packungsbestandteile
Suspension (oral)
 
 
Active AgentDose
Edaravonum105 mg
 
Inactive agentsDoseadditional_information
Cysteini Hydrochloridum Monohydricum  
E 2225 mgconserv.
Natrii Hydroxidum  
Poly(Alcohol Vinylicus)  
Xanthani Gummi  
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home